| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |